PART I Overview We are a life sciences company transforming healthcare innovation by accelerating biomarker breakthroughs from discovery to diagnostics using our ultra-sensitive translational research and spatial biology instruments, consumables, and services. We continue to invest in pushing a paradigm shift in healthcare from an emphasis on later-stage treatment to a focus on earlier detection, monitoring, prognosis, and, ultimately, prevention. Our combined platforms have achieved significant...
Q2 FY2026 — expected 2026-09-13
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-02 | 2025-12-31 | 0001503274-26-000013 | EDGAR | 74K words |
| 2025-03-17 | 2024-12-31 | 0001503274-25-000031 | EDGAR | — |
| 2024-02-29 | 2023-12-31 | 0001558370-24-002205 | EDGAR | — |
| 2023-03-06 | 2022-12-31 | 0001558370-23-002855 | EDGAR | — |
| 2022-03-01 | 2021-12-31 | 0001558370-22-002489 | EDGAR | — |
| 2021-03-05 | 2020-12-31 | 0001558370-21-002469 | EDGAR | — |
| 2020-03-13 | 2019-12-31 | 0001558370-20-002676 | EDGAR | — |
| 2019-03-18 | 2018-12-31 | 0001047469-19-001374 | EDGAR | — |
| 2018-03-19 | 2017-12-31 | 0001047469-18-001842 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-10 | 2025-09-30 | 0001503274-25-000106 | EDGAR | 48K words |
| 2025-08-07 | 2025-06-30 | 0001503274-25-000091 | EDGAR | — |
| 2025-05-12 | 2025-03-31 | 0001503274-25-000054 | EDGAR | — |
| 2024-12-26 | 2024-09-30 | 0001503274-24-000031 | EDGAR | — |
| 2024-08-08 | 2024-06-30 | 0001503274-24-000008 | EDGAR | — |
| 2024-05-08 | 2024-03-31 | 0001558370-24-007299 | EDGAR | — |
| 2023-11-08 | 2023-09-30 | 0001558370-23-018091 | EDGAR | — |
| 2023-08-08 | 2023-06-30 | 0001558370-23-013792 | EDGAR | — |
| 2023-05-09 | 2023-03-31 | 0001558370-23-008898 | EDGAR | — |
| 2022-11-09 | 2022-09-30 | 0001558370-22-017046 | EDGAR | — |
| 2022-08-08 | 2022-06-30 | 0001558370-22-012637 | EDGAR | — |
| 2022-05-10 | 2022-03-31 | 0001558370-22-008128 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-02 | 0001503274-26-000011 | EDGAR | 6K words |
| 2026-01-08 | 0001628280-26-001369 | EDGAR | — |
| 2025-11-20 | 0001628280-25-053420 | EDGAR | — |
| 2025-11-10 | 0001503274-25-000104 | EDGAR | — |
| 2025-10-02 | 0001503274-25-000097 | EDGAR | — |
| 2025-09-24 | 0001104659-25-092669 | EDGAR | — |
| 2025-08-07 | 0001503274-25-000089 | EDGAR | — |
| 2025-08-04 | 0001503274-25-000083 | EDGAR | — |
| 2025-07-24 | 0001503274-25-000080 | EDGAR | — |
| 2025-07-18 | 0001503274-25-000074 | EDGAR | — |
173 total filings indexed. 142 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001503274 |
| Ticker | QTRX |
| Exchange | Nasdaq |
| SIC | 3826: Laboratory Analytical Instruments |
| Incorporated | DE |
| Website | https://www.quanterix.com |
| Listed | 2017-12-07 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report